BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

Conditions

• Mortality Prediction

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• blood sample to check CXCL9 pre stem cell transplant and cell therapy — DIAGNOSTIC_TEST
  Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

Study Details

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Key Dates

First listed

Aug 17, 2026

Start date

Sep 1, 2026

Status verified

Aug 2026

Primary completion

Dec 30, 2030

Completion

Dec 30, 2031

Study Design

Enrollment

124 participants (estimated)

Primary Outcome Measure

Non relapse mortality (NRM) [ Time Frame: NRM at day 100 and at year 1 ]

Central Contacts

• Shatha Farhan, MD
  3137133910
  [email protected]

Locations (1)

Find similar trials in Detroit, MI